Enanta Pharmaceuticals, Inc.ENTANASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending higher, below historical average, slight contraction.
Left:
||||
Price-to-sales ratio
Latest
3.91
↓ 44% below average
Average (9y)
7.03
Historical baseline
Range
High:12.40
Low:2.96
CAGR
-4.1%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2025 | 3.91 | +20.6% |
| 2024 | 3.24 | +9.6% |
| 2023 | 2.96 | -76.2% |
| 2022 | 12.40 | +5.1% |
| 2021 | 11.80 | +58.4% |
| 2020 | 7.45 | +30.0% |
| 2019 | 5.73 | -31.8% |
| 2018 | 8.41 | -3.1% |
| 2017 | 8.68 | +52.1% |
| 2016 | 5.71 | - |